These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23848141)

  • 1. Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo-controlled, double-blind pilot clinical trial.
    Whitmont K; McKelvey KJ; Fulcher G; Reid I; March L; Xue M; Cooper A; Jackson CJ
    Int Wound J; 2015 Aug; 12(4):422-7. PubMed ID: 23848141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical morphine gel in the treatment of painful leg ulcers, a double-blind, placebo-controlled clinical trial: a pilot study.
    Bastami S; Frödin T; Ahlner J; Uppugunduri S
    Int Wound J; 2012 Aug; 9(4):419-27. PubMed ID: 22151619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
    Ajjan RA; Hensor EMA; Del Galdo F; Shams K; Abbas A; Fairclough RJ; Webber L; Pegg L; Freeman A; Taylor AE; Arlt W; Morgan AW; Tahrani AA; Stewart PM; Russell DA; Tiganescu A
    Eur J Endocrinol; 2022 Feb; 186(4):441-455. PubMed ID: 35113805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy.
    Morley S; Griffiths J; Philips G; Moseley H; O'Grady C; Mellish K; Lankester CL; Faris B; Young RJ; Brown SB; Rhodes LE
    Br J Dermatol; 2013 Mar; 168(3):617-24. PubMed ID: 23066973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
    Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
    Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.
    Quatresooz P; Kharfi M; Paquet P; Vroome V; Cauwenbergh G; Piérard GE
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):277-81. PubMed ID: 16503887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G
    Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.
    Balingit PP; Armstrong DG; Reyzelman AM; Bolton L; Verco SJ; Rodgers KE; Nigh KA; diZerega GS
    Wound Repair Regen; 2012; 20(4):482-90. PubMed ID: 22672145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial.
    Squadrito F; Bitto A; Altavilla D; Arcoraci V; De Caridi G; De Feo ME; Corrao S; Pallio G; Sterrantino C; Minutoli L; Saitta A; Vaccaro M; Cucinotta D
    J Clin Endocrinol Metab; 2014 May; 99(5):E746-53. PubMed ID: 24483158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic leg ulcers with topical activated protein C.
    Whitmont K; Reid I; Tritton S; March L; Xue M; Lee M; Fulcher G; Sambrook P; Slobedman E; Cooper A; Jackson C
    Arch Dermatol; 2008 Nov; 144(11):1479-83. PubMed ID: 19015423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C to heal pressure ulcers.
    Wijewardena A; Lajevardi SS; Vandervord E; Vandervord J; Lang TC; Fulcher G; Jackson CJ
    Int Wound J; 2016 Oct; 13(5):986-91. PubMed ID: 25185858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer-study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II.
    Gugerell A; Gouya-Lechner G; Hofbauer H; Laggner M; Trautinger F; Almer G; Peterbauer-Scherb A; Seibold M; Hoetzenecker W; Dreschl C; Mildner M; Ankersmit HJ
    Trials; 2021 Jan; 22(1):10. PubMed ID: 33407796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AVURT: aspirin versus placebo for the treatment of venous leg ulcers - a Phase II pilot randomised controlled trial.
    Tilbrook H; Clark L; Cook L; Bland M; Buckley H; Chetter I; Dumville J; Fenner C; Forsythe R; Gabe R; Harding K; Layton A; Lindsay E; McDaid C; Moffatt C; Rolfe D; Sbizzera I; Stansby G; Torgerson D; Vowden P; Williams L; Hinchliffe R
    Health Technol Assess; 2018 Oct; 22(55):1-138. PubMed ID: 30325305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial.
    Ma C; Hernandez MA; Kirkpatrick VE; Liang LJ; Nouvong AL; Gordon II
    Wounds; 2015 Apr; 27(4):83-91. PubMed ID: 25855851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of omega-3 fatty acid oral therapy on healing of chronic venous leg ulcers in older adults: Study protocol for a randomized controlled single-center trial.
    McDaniel JC; Rausch J; Tan A
    Trials; 2020 Jan; 21(1):93. PubMed ID: 31948466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
    Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
    Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.